Successful Desensitization to Oral Dasatinib in Immediate Hypersensitivity Reaction

A case report is presented, discussing the successful desensitization to dasatinib in a patient with chronic myeloid leukemia (CML) who experienced an immediate hypersensitivity reaction to the drug. The patient had previously been treated with imatinib but developed imatinib-induced pseudoporphyria...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of investigational allergology & clinical immunology 2024-07, Vol.34 (4), p.274-276
Hauptverfasser:	Ruano-Zaragoza, M, Torrent-Rodríguez, A, Araujo-Sanchez, G, Ribó, P, Loli-Ausejo, D, Solis, K, Sánchez-Fernández, M C, Bolaños, J, Bolós, U, López, C, Ruiz, S, Pascal, M, Bartra, J, Muñoz-Cano, R
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Chronic myeloid leukemia Dasatinib - administration & dosage Dasatinib - adverse effects Desensitization, Immunologic - methods Drug Hypersensitivity - diagnosis Drug Hypersensitivity - etiology Drug Hypersensitivity - immunology Drug Hypersensitivity - therapy Exanthema Female Humans Hypersensitivity (immediate) Hypersensitivity, Immediate - etiology Hypersensitivity, Immediate - immunology Imatinib Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy Leukemia, Myelogenous, Chronic, BCR-ABL Positive - immunology Leukocytes (basophilic) Male Middle Aged Myeloid leukemia Protein Kinase Inhibitors - administration & dosage Protein Kinase Inhibitors - adverse effects Skin tests Tyrosine kinase inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!